Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Medetomidine
Medetomidine is an alpha-2 adrenergic agonist used in veterinary medicine for its sedative, analgesic, and muscle relaxant properties in horses. It acts on the central nervous system by binding to alpha-2 adrenergic receptors, resulting in decreased release of norepinephrine and subsequent sedation. Medetomidine is employed in various clinical settings, including premedication for anesthesia, minor surgical procedures, and managing pain. The effects of medetomidine can be reversed with the administration of atipamezole, an alpha-2 adrenergic antagonist. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacodynamics, pharmacokinetics, and clinical applications of medetomidine in equine practice.
Comparison of the sedative effects of medetomidine and xylazine in horses. The sedative effects in horses of the new alpha 2 agonist medetomidine were compared with those of xylazine. Four ponies and one horse were treated on separate occasions with two doses of medetomidine (5 micrograms/kg bodyweight and 10 micrograms/kg bodyweight) and with one dose of xylazine (1 mg/kg bodyweight) given by intravenous injection. Medetomidine at 10 micrograms/kg was similar to 1 mg/kg xylazine in its sedative effect but produced more severe and more prolonged ataxia, and one animal fell over during the study. Medetomidine at 5 micrograms/kg produced less sedation but a similar deg...
